Evaluation of riboflavin and ultraviolet light treatment against Klebsiella pneumoniae in whole blood-derived platelets: A pilot study
- PMID: 33687079
- DOI: 10.1111/trf.16347
Evaluation of riboflavin and ultraviolet light treatment against Klebsiella pneumoniae in whole blood-derived platelets: A pilot study
Abstract
Background: Bacterial contamination of platelet concentrates (PCs) is the predominant cause of infectious transfusion reactions. The Pathogen Inactivation Mirasol system was implemented at the King Faisal Specialist Hospital (Saudi Arabia) to reduce the risk of transfusing contaminated PCs. This pilot study evaluated the effectiveness of Mirasol against Klebsiella pneumoniae, a pathogen associated with transfusion reactions, in whole blood-derived PCs.
Study design and methods: Whole blood (WB) units inoculated with one of six K. pneumoniae strains (five clinical isolates and ATCC-700603) at a concentration of 3-38 CFU/unit, were processed using the platelet-rich plasma (PRP) method. Each spiked PC was pooled with four unspiked units. The pooled PC was split into three Mirasol storage bags: an untreated unit (control), and two units treated with Mirasol at 26 and 32 h post-WB collection, respectively. PC samples obtained before and after Mirasol treatment were used for BacT/ALERT cultures and determination of bacteria quantification. Each experiment was repeated three independent times.
Results: Five strains were detected prior to PC treatment (24 h post-WB spiking), while one clinical isolate was not detected. Mirasol treatment after 26 h of WB collection resulted in complete inactivation of all K. pneumoniae strains. However, treatment 32 h post-WB collection resulted in the breakthrough of one clinical isolate in two of the three replicates with ~7.8 log10 CFU/unit detected on day 5 of PC storage.
Conclusion: Delayed Mirasol treatment from 26 to 32 h post-WB collection, resulted in one breakthrough. These results highlight the importance of minimizing the time between WB collection and PI treatment.
Keywords: Klebsiella pneumoniae; Mirasol; pathogen inactivation; platelet; whole blood.
© 2021 AABB.
References
REFEREENCES
-
- Hong H, Xiao W, Lazarus HM, Good CE, Maitta RW, Jacobs MR. Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance. Blood. 2016;127:496-502.
-
- Ramirez-Arcos S, Goldman M. Bacterial contamination. Transfusion reactions. 4th ed. Bethesda: American Association of Blood Banks; 2012. p. 53-181.
-
- De Korte D, Marcelis J. Platelet concentrates: Reducing the risk of transfusion transmitted bacterial infections. Int J Clin Trans Med. 2014;2:29-37.
-
- FDA. Fatalities reported to FDA following blood collection and transfusion annual summary for fiscal year 2016. 2016. [cited 2020 Mar 25]. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/....
-
- Ramirez-Arcos S, DiFranco C, Mclntyre T, Goldman M. Residual risk of bacterial contamination of platelets: Six years of experience with sterility testing. Transfusion. 2017;57:2174-81.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous